PMID: 9444991Jan 28, 1998Paper

Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides

Journal of Virology
L T RimskyT J Matthews

Abstract

A synthetic peptide, DP178, containing amino acids 127 to 162 of the human immunodeficiency virus type 1 (HIV-1) gp41 Env glycoprotein, is a potent inhibitor of virus infection and virus mediated cell-to-cell fusion (C. Wild, T. Greenwell, and T. Matthews, AIDS Res. Hum. Retroviruses 9:1051-1053, 1993). In an effort to understand the mechanism of action of this peptide, we derived resistant variants of HIV-1(IIIB) and NL4-3 by serial virus passage in the presence of increasing doses of the peptide. Sequence analysis of the resistant isolates suggested that a contiguous 3-amino-acid sequence within the amino-terminal heptad repeat motif of gp41 was associated with resistance. Site-directed mutagenesis studies confirmed this observation and indicated that changes in two of these three residues were necessary for development of the resistant phenotype. Direct binding of DP178 to recombinant protein and synthetic peptide analogs containing the wild-type and mutant heptad repeat sequences revealed a strong correlation between DP178 binding and the biological sensitivity of the corresponding virus isolates to DP178. The results are discussed from the standpoints of the mechanism of action of DP178 and recent crystallographic informat...Continue Reading

References

Nov 1, 1992·International Journal of Cell Cloning·Q J Sattentau
Nov 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·C WildT Matthews
Aug 1, 1991·The Journal of Experimental Medicine·Q J Sattentau, J P Moore
Mar 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·T K HartP J Bugelski
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·E O FreedR Risser
Nov 23, 1990·Science·J P MooreQ J Sattentau
Jun 1, 1990·AIDS Research and Human Retroviruses·E L DelwartT Gilmore
Aug 1, 1989·AIDS Research and Human Retroviruses·W R GallaherR C Montelaro
Jan 1, 1985·Cell·S Wain-HobsonM Alizon
May 1, 1995·Journal of Virology·H B BernsteinE Hunter
Aug 1, 1994·Immunological Reviews·T J MatthewsM L Greenberg
Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·C T WildT J Matthews
Nov 1, 1993·AIDS Research and Human Retroviruses·C WildT Matthews
Mar 5, 1996·Proceedings of the National Academy of Sciences of the United States of America·D M LambertS R Petteway
Dec 1, 1995·Nature Structural Biology·M LuP S Kim
Sep 1, 1996·Immunology Letters·Y H Chen, M P Dierich
Nov 5, 1996·Biochemistry·M D Rabenstein, Y K Shin
May 22, 1997·Nature·W WeissenhornD C Wiley
Jun 10, 1997·Proceedings of the National Academy of Sciences of the United States of America·W WeissenhornD C Wiley

❮ Previous
Next ❯

Citations

Apr 18, 1998·Nature Structural Biology·R A FurutaC D Weiss
Nov 11, 1998·Nature Medicine·D D Richman
Dec 5, 2000·Journal of Acquired Immune Deficiency Syndromes : JAIDS·C L TremblayM S Hirsch
Feb 15, 2001·Current Infectious Disease Reports·Georgia D. Tomaras, Michael L. Greenberg
Jan 12, 2001·AIDS Research and Human Retroviruses·C H ChenT J Matthews
Jan 31, 2002·Annual Review of Medicine·Jon H CondraEmilio A Emini
Apr 30, 2002·Current Opinion in Infectious Diseases·N Cammack
Dec 28, 2002·Journal of Virology·Béatrice LabrosseFabrizio Mammano
Nov 19, 2002·Antimicrobial Agents and Chemotherapy·Valery FikkertMyriam Witvrouw
Nov 30, 2002·Expert Opinion on Investigational Drugs·Ray Y ChenMichael S Saag
May 30, 2003·The New England Journal of Medicine·Adriano LazzarinUNKNOWN TORO 2 Study Group
Sep 10, 2003·Proceedings of the National Academy of Sciences of the United States of America·John P Moore, Robert W Doms
Mar 6, 2004·HIV Clinical Trials·David Asboe
Mar 5, 2004·The New England Journal of Medicine·François Clavel, Allan J Hance
Jul 23, 2004·The Journal of General Virology·Katsunori Okazaki, Hiroshi Kida
Dec 24, 2004·Antimicrobial Agents and Chemotherapy·Elin AnderssonBo Svennerholm
Jun 3, 2005·AIDS Research and Human Retroviruses·Avelin Fobang AghokengMartine Peeters
Jul 5, 2005·Expert Opinion on Investigational Drugs·J M Kilby
Feb 9, 2006·The Journal of Antimicrobial Chemotherapy·Verónica BrizVincent Soriano
Mar 17, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Kalpana Dhiraj AgnihotriRamesh S Paranjape
Jun 19, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yael Wexler-Cohen, Yechiel Shai
Apr 25, 2008·Journal of Virology·Dirk EgginkBen Berkhout
May 16, 2008·Journal of Virology·Chris Baldwin, Ben Berkhout
Mar 4, 2009·Annual Review of Biochemistry·Peter M Colman
Sep 22, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Timothy J HenrichDaniel R Kuritzkes
Jul 28, 2010·Proceedings of the National Academy of Sciences of the United States of America·Gregory H BirdLoren D Walensky
Jan 25, 2011·European Biophysics Journal : EBJ·Avraham Ashkenazi, Yechiel Shai
Feb 24, 2011·Scandinavian Journal of Infectious Diseases·Charlotte CharpentierLaurence Weiss
May 1, 2010·Viruses·Michael A LobritzEric J Arts

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.